Insulin glargine, recombinant Subcutaneous and Oramorph SR
Determining the interaction of Insulin glargine, recombinant Subcutaneous and Oramorph SR and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin glargine
Brand name: Basaglar KwikPen, Lantus, Lantus Solostar Pen, Toujeo SoloStar, Lantus OptiClik Cartridge, Toujeo Max SoloStar, Lantus SoloStar
Synonyms: Insulin glargine, Insulin Glargine
Generic Name: morphine
Brand name: Arymo ER, Kadian, MorphaBond ER, Avinza, MS Contin, Duramorph PF, Infumorph, Mitigo, RMS, Roxanol
Synonyms: Oramorph SR (Oral)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin glargine, recombinant Subcutaneous-Orap
- Insulin glargine, recombinant Subcutaneous-Orapred
- Insulin glargine, recombinant Subcutaneous-Orapred ODT
- Insulin glargine, recombinant Subcutaneous-Oraqix
- Insulin glargine, recombinant Subcutaneous-Orasol
- Insulin glargine, recombinant Subcutaneous-OraVerse
- Oramorph SR-Insulin glulisine
- Oramorph SR-Insulin Glulisine (Cartridges and Pens)
- Oramorph SR-Insulin Glulisine (Vials)
- Oramorph SR-Insulin glulisine Subcutaneous
- Oramorph SR-Insulin human inhaled Inhalation
- Oramorph SR-Insulin human regular Injection